JMI LABS IS NOW PART OF LEARN MORE

Antimicrobial activities of ceftaroline and comparator agents against bacterial organisms causing bacteremia in patients with skin and skin structure infections in U.S. Medical Centers, 2008 to 2014.

Antimicrobial activities of ceftaroline and comparator agents against bacterial organisms causing bacteremia in patients with skin and skin structure infections in U.S. Medical Centers, 2008 to 2014. by Sader HS, Flamm RK, Mendes RE, Farrell DJ and Jones RN published in Antimicrob. Agents. Chemother. 2016; 60 (4): 2558-2563

Nosocomial Candidiasis: Antifungal stewardship and the importance of rapid diagnosis.

Nosocomial Candidiasis: Antifungal stewardship and the importance of rapid diagnosis. by Pfaller MA and Castanheira M published in Med. Mycol. 2016; 54 (1): 1-22

Klebsiella pneumoniae from a New York City hospital belonging to ST258 and carrying blaKPC-2- and blaVIM-4-encoding genes.

Klebsiella pneumoniae from a New York City hospital belonging to ST258 and carrying blaKPC-2- and blaVIM-4-encoding genes. by Castanheira M, Deshpande LM, Mills JC, Jones RN, Soave R, Jenkins SG and Schuetz AN published in Antimicrob. Agents. Chemother. 2016; 60 (3): 1924-1927

Results from oritavancin resistance surveillance programs (2011-2014): Clarification for using vancomycin as a surrogate to infer oritavancin susceptibility.

Results from oritavancin resistance surveillance programs (2011-2014): Clarification for using vancomycin as a surrogate to infer oritavancin susceptibility. by Jones RN, Moeck G, Arhin FF, Dudley MN, Rhomberg PR and Mendes RE published in Antimicrob. Agents. Chemother. 2016; 60 (5): 3174-3177

Reproducibility of dalbavancin MIC test results and an updated surrogate accuracy analysis of vancomycin MIC values to infer dalbavancin susceptibility (2014).

Reproducibility of dalbavancin MIC test results and an updated surrogate accuracy analysis of vancomycin MIC values to infer dalbavancin susceptibility (2014). by Jones RN, Rhomberg PR and Mendes RE. published in Diag. Microbio. Infect. Dis. 2016; 86 (2): 249-251

Antimicrobial activity of ceftaroline and comparator agents when tested against numerous species of coagulase-negative Staphylococcus causing infection in US hospitals.

Antimicrobial activity of ceftaroline and comparator agents when tested against numerous species of coagulase-negative Staphylococcus causing infection in US hospitals. by Sader HS, Farrell DJ, Flamm RK, Streit JM, Mendes RE and Jones RN. published in Diagn. Microbiol. Infect. Dis. 2016; 85 (1): 80-84

Report of Linezolid Activity from the LEADER Program for 2014: Monitoring Resistance Trends and Mechanisms

Report of Linezolid Activity from the LEADER Program for 2014: Monitoring Resistance Trends and Mechanisms, Lead author: Flamm RK, presented at ID Week, October 7-11, 2015, San Diego, CA

In Vitro Antibacterial Activity of Meropenem/RPX709, (a Carpabenem/ß-lactamase Inhibitor Combination) Against Contemporary Enterobacteriaceae Isolated from Intra-abdominal and Urinary Tract Infections in the United States

In Vitro Antibacterial Activity of Meropenem/RPX709, (a Carpabenem/ß-lactamase Inhibitor Combination) Against Contemporary Enterobacteriaceae Isolated from Intra-abdominal and Urinary Tract Infections in the United States, Lead author: Castanheira M, presented at ID Week, October 7-11, 2015, San Diego, CA

Contemporary Analysis of Oritavancin Activity Against S. aureus Responsible for Invasive Community- and Hospital-associated Infections in the USA (2013-2014)

Contemporary Analysis of Oritavancin Activity Against S. aureus Responsible for Invasive Community- and Hospital-associated Infections in the USA (2013-2014), Lead author: Mendes Re, presented at ID Week, October 7-11, 2015, San Diego, CA

Activity of Ceftaroline Organisms Causing Bacteremia in Patients with SSSI in USA Medical Centers (2008-2014)

Activity of Ceftaroline Organisms Causing Bacteremia in Patients with SSSI in USA Medical Centers (2008-2014), Lead author: Sader HS, presented at ID Week, October 7-11, 2015, San Diego, CA

Activity of Ceftazidime-avibactam and Comparator Agents tested against Gram-negative Organisms Isolated from Urinary tract infections (UTI): Results from the International Network for Optimal Resistance Monitoring (INFORM) Program

Activity of Ceftazidime-avibactam and Comparator Agents tested against Gram-negative Organisms Isolated from Urinary tract infections (UTI): Results from the International Network for Optimal Resistance Monitoring (INFORM) Program, Lead author: Sader HS, presented at ID Week, October 7-11, 2015, San Diego, CA

Comparative Evaluation of the Antimicrobial Susceptibility Patterns of Community-and Hospital-Acquired MRSA from USA Hospitals by Site of Infection: Results from AWARE (2012-2014)

Comparative Evaluation of the Antimicrobial Susceptibility Patterns of Community-and Hospital-Acquired MRSA from USA Hospitals by Site of Infection: Results from AWARE (2012-2014), Lead author: Sader HS, presented at ID Week, October 7-11, 2015, San Diego, CA

The Actvity of Tedizolid against Gram-positive Pathogens from USA Medical Centers: 2014 Surveillance

The Actvity of Tedizolid against Gram-positive Pathogens from USA Medical Centers: 2014 Surveillance, Lead author: Farrell DJ, presented at ID Week, October 7-11, 2015, San Diego, CA

Analysis of Telavancin Activity Against a USA Collection of S. aureus Clinical Isolates Causing HAP (2013-2014)

Analysis of Telavancin Activity Against a USA Collection of S. aureus Clinical Isolates Causing HAP (2013-2014), Lead author: Mendes RE, presented at ID Week, October 7-11, 2015, San Diego, CA

Activity of Omadacycline Tested Against S. aureus from a Global Surveillance Program (2014)

Activity of Omadacycline Tested Against S. aureus from a Global Surveillance Program (2014), Lead author: Flamm RK, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

In Vitro Activity of Minocycline Against A. baumannii, S. maltophilia and B. cepacia Isolated in 2013 from a Global Surveillance Program

In Vitro Activity of Minocycline Against A. baumannii, S. maltophilia and B. cepacia Isolated in 2013 from a Global Surveillance Program, Lead author: Flamm RK, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

Evaluation of Carbapenemase Detection Methods Using a Challenging Collection of Enterobacteriaceae Isolates

Evaluation of Carbapenemase Detection Methods Using a Challenging Collection of Enterobacteriaceae Isolates, Lead author: Castanheira M, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

Performance of BD MAX™ StaphSR against S. aureus Clinical Isolates from the 9 USA Census Regions

Performance of BD MAX™ StaphSR against S. aureus Clinical Isolates from the 9 USA Census Regions, Lead author: Mendes RE, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

Oritavancin In Vitro Activity Against a Collection of Molecularly-characterized Staph and Enterococci with Elevated Linezolid MICs

Oritavancin In Vitro Activity Against a Collection of Molecularly-characterized Staph and Enterococci with Elevated Linezolid MICs, Lead author: Mendes RE, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

Update of Telavancin in vitro Activity Against a USA collection of Gram-Positive Clinical Isolates (2014) Causing Skin and Skin Structure Infections

Update of Telavancin in vitro Activity Against a USA collection of Gram-Positive Clinical Isolates (2014) Causing Skin and Skin Structure Infections, Lead author: Mendes RE, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

Activity of Omadacycline Tested against Enterobacteriaceae Causing Urinary Tract Infections from a Global Surveillance Porgram (2014)

Activity of Omadacycline Tested against Enterobacteriaceae Causing Urinary Tract Infections from a Global Surveillance Porgram (2014), Lead author: Flamm RK, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

Activity of Lefamulin, an Pleuromutilin Derivative, against S. aureus Strains with Decreased Susceptibility to Vancomycin

Activity of Lefamulin, an Pleuromutilin Derivative, against S. aureus Strains with Decreased Susceptibility to Vancomycin, Lead author: Sader HS, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

Solithromycin MIC and Disk Diffusion Quality Control Ranges, a CLSI Multi-Laboratory M23-A3 Study Design

Solithromycin MIC and Disk Diffusion Quality Control Ranges, a CLSI Multi-Laboratory M23-A3 Study Design, Lead author: Ross JE, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

Plazomicin (PLZ) Activity Against Contemporary Clinical Isolates Collected in USA Hospitals

Plazomicin (PLZ) Activity Against Contemporary Clinical Isolates Collected in USA Hospitals, Lead author: Castanheira M, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

In vitro Activity of Tedizolid Against Gram-positive Pathogens Isolated from Patients SSSI in the US and EU During 2014

In vitro Activity of Tedizolid Against Gram-positive Pathogens Isolated from Patients SSSI in the US and EU During 2014, Lead author: Farrell DJ, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

In Vitro Activity of Pexiganan Tested Against Pathogens with Elevated MICs to Topical Antimicrobials

In Vitro Activity of Pexiganan Tested Against Pathogens with Elevated MICs to Topical Antimicrobials, Lead author: Flamm RK, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

Activity of a Long-acting Echincandin (CD101) and Comparator Antifungal Agents against Contemporary Invasive Fungal Isolates

Activity of a Long-acting Echincandin (CD101) and Comparator Antifungal Agents against Contemporary Invasive Fungal Isolates, Lead author: Castanheira M, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

Ceftobiprole Activity When Tested Against Clinical Bacterial Pathogens from Europe, Turkey and Israel 2014

Ceftobiprole Activity When Tested Against Clinical Bacterial Pathogens from Europe, Turkey and Israel 2014, Lead author: Farrell DJ, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

Activity of Solithromycin Against Pathogens Associated with CABP: Global Surveillance Results from 2014

Activity of Solithromycin Against Pathogens Associated with CABP: Global Surveillance Results from 2014, Lead author: Farrell DJ, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

Activity of Omadacycline Tested against Streptococcus pneumoniae from a Global Surveillance Porgram (2014)

Activity of Omadacycline Tested against Streptococcus pneumoniae from a Global Surveillance Porgram (2014), Lead author: Flamm RK, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

CAZ-AVI Activity Against CAZ-NS Citrobacter spp., Enterobacter spp,. S. marcescens, and P. aeruginosa from USA (2011-2014)

CAZ-AVI Activity Against CAZ-NS Citrobacter spp., Enterobacter spp,. S. marcescens, and P. aeruginosa from USA (2011-2014), Lead author: Sader HS, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

Activity of Meropenem/RPX7009 Against Contemporary Enterobacteriaceae Isolates Collected from BSI in USA Hospitals

Activity of Meropenem/RPX7009 Against Contemporary Enterobacteriaceae Isolates Collected from BSI in USA Hospitals, Lead author: Castanheira M, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

Update of Oritavancin ad Comparator Agent Activities Against Gram-Positive Isolates Responsible for Documented SSSI in the USA (2014)

Update of Oritavancin ad Comparator Agent Activities Against Gram-Positive Isolates Responsible for Documented SSSI in the USA (2014), Lead author: Mendes RE, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

In Vitro Activity of Delafloxacin Tested Against Streptococcus pneumoniae, Haemophilus influenza, and Moraxella catarrhalis

In Vitro Activity of Delafloxacin Tested Against Streptococcus pneumoniae, Haemophilus influenza, and Moraxella catarrhalis, Lead author: Flamm RK, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

Activity of CAZ-AVI against Contemoprary PSA from USA Medical Centers by Census Region

Activity of CAZ-AVI against Contemoprary PSA from USA Medical Centers by Census Region, Lead author: Huband MD, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

In Vitro Activity of Tedizolid against Streptococci and Enterococci Isolated from the United States and Europe in 2014

In Vitro Activity of Tedizolid against Streptococci and Enterococci Isolated from the United States and Europe in 2014, Lead author: Farrell DJ, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

ß-Lactamase Characterization Enterobacteriaceae Baseline Pathogens from Two Phase 3 Trials of CAZ-AVI

ß-Lactamase Characterization Enterobacteriaceae Baseline Pathogens from Two Phase 3 Trials of CAZ-AVI, Lead author: Mendes RE, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

Trends in ß-Lactamase Occurrence in USA (2012-2014) and Activity of CAZ-AVI Against a Large Collection of BL Producing Isolates

Trends in ß-Lactamase Occurrence in USA (2012-2014) and Activity of CAZ-AVI Against a Large Collection of BL Producing Isolates, Lead author: Castanheira M, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

CAZ-AVI Activity against Aerobic Gram-negative Organisms Isolated from IAI in USA Hospitals (2012-2014)

CAZ-AVI Activity against Aerobic Gram-negative Organisms Isolated from IAI in USA Hospitals (2012-2014), Lead author: Sader HS, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

Report of Linezolid Activity from the ZAAPS Program 2014 (EU, LA, APAC, Cananda)

Report of Linezolid Activity from the ZAAPS Program 2014 (EU, LA, APAC, Cananda), Lead author: Flamm RK, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

Antimicrobial Activity of Ceftaroline and Comparator Agents when Tested Against Numerous Species of CoNS

Antimicrobial Activity of Ceftaroline and Comparator Agents when Tested Against Numerous Species of CoNS, Lead author: Sader HS, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

Activity of Fusidic Acid against Staphylococci Isolated from Patients in United States Hospitals During 2014

Activity of Fusidic Acid against Staphylococci Isolated from Patients in United States Hospitals During 2014, Lead author: Farrell DJ, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

Activity of ceftolozane/tazobactam against Enterobacteriaceae, P. aeruginosa and S. pneumoniae from USA and EU Hospitals (2014)

Activity of ceftolozane/tazobactam against Enterobacteriaceae, P. aeruginosa and S. pneumoniae from USA and EU Hospitals (2014), Lead author: Farrell DJ, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA

In vitro activity of oritavancin against streptococci, including macrolide- and/or lincosamide (constitutive)-resistant and MDR isolates from EU hospitals (2010-2013)

In vitro activity of oritavancin against streptococci, including macrolide- and/or lincosamide (constitutive)-resistant and MDR isolates from EU hospitals (2010-2013), Lead author: Mendes RE, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark

Debio 1452 MIC QC Range with S. aureus ATCC 29213 Using a Multi-laboratory Study Design

Debio 1452 MIC QC Range with S. aureus ATCC 29213 Using a Multi-laboratory Study Design, Lead author: Flamm RK, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark

Tigecycline activity tested against >11,000 isolates of Acinetobacter spp. collected worldwide in 2004-2013

Tigecycline activity tested against >11,000 isolates of Acinetobacter spp. collected worldwide in 2004-2013, Lead author: Sader HS, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark

In vitro activity of dalbavancin tested against S. pneumoniae responsible for documented infection in medical centres in five continents worldwide (2011-2013)

In vitro activity of dalbavancin tested against S. pneumoniae responsible for documented infection in medical centres in five continents worldwide (2011-2013), Lead author: Mendes RE, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark

Sustained potent activity of dalbavancin when tested against MDR staphylococcal and streptococcal isolates responsible for documented infection in EU (2011-2013)

Sustained potent activity of dalbavancin when tested against MDR staphylococcal and streptococcal isolates responsible for documented infection in EU (2011-2013), Lead author: Mendes RE, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark

Antimicrobial potency of lefamulin (BC-3781) tested against S. pneumoniae with defined serotypes, including MDR isolates causing lower RTI in the USA

Antimicrobial potency of lefamulin (BC-3781) tested against S. pneumoniae with defined serotypes, including MDR isolates causing lower RTI in the USA, Lead author: Mendes RE, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark

Accuracy of Predicting Oritavancin Susceptibility using Vancomycin Surrogate Susceptibility Testing of GP from EU

Accuracy of Predicting Oritavancin Susceptibility using Vancomycin Surrogate Susceptibility Testing of GP from EU, Lead author: Jones RN, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark